Detalhe da pesquisa
1.
A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens.
Allergy
; 74(12): 2461-2478, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31228873
2.
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
Haematologica
; 103(5): 799-809, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439183
3.
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.
Blood
; 126(26): 2832-41, 2015 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26486787
4.
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.
Haematologica
; 102(9): 1519-1529, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596283
5.
Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy.
J Immunol
; 194(8): 4008-18, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25786690
6.
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.
Nature
; 478(7370): 524-8, 2011 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21814200
7.
Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.
J Allergy Clin Immunol
; 137(2): 601-609.e8, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26518092
8.
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia.
Blood
; 123(25): 3951-62, 2014 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24778155
9.
A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection.
Blood
; 124(1): 111-20, 2014 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24677542
10.
Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine.
J Immunol
; 192(10): 4867-75, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24733847
11.
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
J Allergy Clin Immunol
; 135(5): 1207-7.e1-11, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25441634
12.
CD52 is a molecular target in advanced systemic mastocytosis.
FASEB J
; 28(8): 3540-51, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24760752
13.
A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
J Immunol
; 190(7): 3068-78, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23440415
14.
Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5.
J Allergy Clin Immunol
; 133(3): 836-45.e11, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24182774
15.
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand.
Blood
; 119(18): 4242-52, 2012 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22438247
16.
DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.
Eur J Clin Invest
; 44(12): 1239-45, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25371066
17.
Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V.
Haematologica
; 98(9): 1450-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23539538
18.
Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms.
FASEB J
; 26(2): 894-906, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22051730
19.
Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
J Immunol
; 186(9): 5333-44, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21451110
20.
Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy.
J Allergy Clin Immunol
; 130(2): 435-43.e4, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22789398